American College of Rheumatology

American College of Rheumatology Global medical society providing education, research, advocacy, and practice management support to over 10,500 rheumatology professionals since 1934.

The ACR CareerConnection is more than job postings. When you’re not quite sure of the direction you want your career to ...
12/29/2025

The ACR CareerConnection is more than job postings. When you’re not quite sure of the direction you want your career to go or you’re struggling with burnout or telling your professional story, the ACR’s exclusive career site offers:

💻 One-stop career planning portal
🚀 Motivational blog content to take you to the next level
🤝 Personalized guidance with private career coaching

Career advice at your fingertips! LEARN more and move your rheumatology career forward with confidence TODAY → https://acr.tw/2T1fw48

Where science meets sunshine! ☀️ Join the global rheumatology community at ACR Convergence 2026, November 6-11, in Orlan...
12/28/2025

Where science meets sunshine! ☀️ Join the global rheumatology community at ACR Convergence 2026, November 6-11, in Orlando, Florida.

Save the dates and get ready for world-class education with a little magic. Stay tuned for more information about member-only registration in the New Year.

ACR podcasts are turning off the mic for a few weeks, but now is the perfect time to catch up on shows you might have mi...
12/27/2025

ACR podcasts are turning off the mic for a few weeks, but now is the perfect time to catch up on shows you might have missed! 🎙️ From expert insights to cutting-edge rheumatology research, our episodes cover it all. Have a listen! 👂🎧 https://acr.tw/41ymm1Y

For decades, malignant atrophic papulosis (Degos disease) was described in the literature as uniformly fatal. Dr. Lee Sc...
12/26/2025

For decades, malignant atrophic papulosis (Degos disease) was described in the literature as uniformly fatal. Dr. Lee Schulman Shapiro shares the remarkable story of treating a rapidly declining 16-year-old patient, the scientific and clinical detective work that followed, and how these efforts have opened the door to new therapeutic possibilities and improved survival. LISTEN → https://acr.tw/4rSLN9b

Snowmass is calling! 🏔️ Join us January 25–29, 2026, for the ACR Winter Rheumatology Symposium, the ACR’s winter hub for...
12/24/2025

Snowmass is calling! 🏔️ Join us January 25–29, 2026, for the ACR Winter Rheumatology Symposium, the ACR’s winter hub for top-tier rheumatology learning. Cool programs, epic views. Register TODAY → https://acr.tw/3PkNafU

“VEXAS is a recently characterized disease with a lot of unknowns,” says Physician Editor Bharat Kumar, MD, MME, FACP, F...
12/23/2025

“VEXAS is a recently characterized disease with a lot of unknowns,” says Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS. “Fortunately, the ACR has published a guidance statement to help with its diagnosis and management. Be sure to read this article to learn what to watch for and how to treat this rare condition with a genetic component.”

VIEW in this month’s issue of The → https://acr.tw/4pRyW5Y

If you missed ACR Convergence 2025, you don’t have to miss out on the Year in Review. Catch up online and hear leading e...
12/22/2025

If you missed ACR Convergence 2025, you don’t have to miss out on the Year in Review. Catch up online and hear leading experts in clinical and basic science rheumatology research share key breakthroughs, diagnostic insights, and treatment strategies that are shaping the future of clinical practice.

ACR/ARP members receive a discount on this course. Those who attended the meeting already have access to the original recording. DETAILS → https://acr.tw/3N26z6g

Plenty of new papers to catch up on in Arthritis Care & Research!Update on impact of arthritis on US adults:•Prevalence ...
12/20/2025

Plenty of new papers to catch up on in Arthritis Care & Research!

Update on impact of arthritis on US adults:
•Prevalence of arthritis-attributable activity limitations
https://doi.org/10.1002/acr.70018
•Prevalence of arthritis & nonmedical factors that influence health
https://doi.org/10.1002/acr.70020
•Prevalence of arthritis-attributable work limitations among adults w/ arthritis
https://doi.org/10.1002/acr.25683

Change in dx, and achievement of drug-free remission in patients w/ seronegative RA
https://doi.org/10.1002/acr.70011

Module w/ simulated experience & genAI assistance to help FITs write letters for disability accommodation
https://doi.org/10.1002/acr.70006

Relationships of dietary diversity score w/ risk of incident gout
https://doi.org/10.1002/acr.70012

Metabolic signatures assoc. w/ long-term air pollution exposure that may be linked to elevated gout risk
https://doi.org/10.1002/acr.70007

Mortality trends in people w/ acute myocardial infarction & RA
https://doi.org/10.1002/acr.70009

RCT: Cognitive behavioral therapy for youth w/ childhood-onset lupus
https://doi.org/10.1002/acr.70010

Biomarker score of MUC5B, MMP-7, & anti-MAA improves RA-ILD risk stratification
https://doi.org/10.1002/acr.70008

Distinct biomarker patterns in systemic JIA lung disease
https://doi.org/10.1002/acr.70015

Discover the Secrets and Pearls of Rheumatology from ACR Convergence 2025—now available online! Explore expert insights ...
12/20/2025

Discover the Secrets and Pearls of Rheumatology from ACR Convergence 2025—now available online! Explore expert insights on lupus, connective tissue disorders, and complex autoimmunity, and take away diagnostic and therapeutic strategies to advance your practice.

ACR/ARP members receive a discount on this course. Those who attended the meeting already have access to the original recording. DETAILS → https://acr.tw/3YtqtcO

LISTEN in as Dr. Haaversen reflects on how her findings may inform future GCA guidelines and shares how large-vessel ima...
12/19/2025

LISTEN in as Dr. Haaversen reflects on how her findings may inform future GCA guidelines and shares how large-vessel imaging became a central focus of her work. The episode closes with a discussion on integrating advanced diagnostics with strong clinician-patient communication → https://acr.tw/4rKkFcl

New ACR VEXAS guidance published, inflammatory disease, what’s new in PsA, and prednisone or MTX for pulmonary sarcoidos...
12/19/2025

New ACR VEXAS guidance published, inflammatory disease, what’s new in PsA, and prednisone or MTX for pulmonary sarcoidosis—this week in The .

▶️First ACR Guidance Statement for VEXAS Released
https://acr.tw/4pRyW5Y

▶️Study: Inflammation Starts Earlier Than You Think
https://acr.tw/4alS1Z3

▶️What’s New in Psoriatic Arthritis?
https://acr.tw/48ZZESy

▶️Prednisone or Methotrexate for Pulmonary Sarcoidosis?
https://acr.tw/454Ow5G

12/19/2025

✨ Early registration is OPEN for the State-of-the-Art Clinical Symposium (SOTA) 2026, April 24-26, in Rosemont, Illinois (approximately 20 minutes northwest of Chicago, near O’Hare International Airport) and we can’t wait to see you! Lock in your savings now and register TODAY → https://acr.tw/44N127p

Address

2200 Lake Boulevard NE
Atlanta, GA
30319

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+14046333777

Website

Alerts

Be the first to know and let us send you an email when American College of Rheumatology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category